News

Veracyte’s Envisia Classifier Improves ILD/IPF Diagnosis, Study Says

Envisia Genomic Classifier — a non-invasive diagnostic test developed by Veracyte and used as a complement to high-resolution computed tomography (HRCT) imaging — improves diagnosis of interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) compared with HRCT alone, according to a recent study. The findings were published…

Increased Honeycombing Areas a Prognostic Factor in IPF, Study Finds

Quantification of so-called honeycombing areas (patches of cystic spaces) in the lungs seen through high-resolution computed tomography (HRCT) may be a predictor of mortality in people with idiopathic pulmonary fibrosis (IPF), according to a retrospective analysis. The study, “Quantitative CT analysis of honeycombing area predicts mortality in…

Oxygen Manifesto, Part 1: Advice from 3 Respiratory Specialists

Note: This is the first article of a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem.  One of the more hotly debated topics in the treatment of respiratory disease is supplemental oxygen use. Participants in the debate often…

Broadway Belts For PFF! Raises Record $400,000 for PF Foundation

This year’s edition of Broadway Belts For PFF! — a benefit event for the Pulmonary Fibrosis Foundation (PFF) — raised a record $400,000 to help fund pulmonary fibrosis (PF) research and patient programs. The evening of music, comedy, and performances at New York’s Edison Ballroom was hosted by Broadway…